[1] RAMGOPAL S, WILSON P M, FLORIN T A. Diagnosis and management of neonatal herpes simplex infection in the emergency department[J]. Pediatr Emerg Care,2020,36(4):196-202. [2] FLAGG E W, WEINSTOCK H. Incidence of neonatal herpes simplex virus infections in the United States, 2006[J]. Pediatrics, 2011, 127(1):e1-e8. [3] ROBERTS S. Herpes simplex virus: incidence of neonatal herpes simplex virus, maternal screening, management during pregnancy, and HIV[J]. Curr Opin Obstet Gynecol, 2009, 21(2):124-130. [4] MAHNERT N, ROBERTS S W, LAIBL VR, et al. The incidence of neonatal herpes infection[J]. Am J Obstet Gynecol, 2007,196(5):e55-e56. [5] BERNSTEIN D I, BELLAMY A R, HOOK E W, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women[J]. Clin Infect Dis, 2013, 56(3):344-351. [6] SCHILLINGER J A, MCKINNEY C M, GARG R, et al. Seroprevalence of herpes simplex virus type 2 and characteristics associated with undiagnosed infection: New York City, 2004[J]. Sex Transm Dis, 2008, 35(6):599-606. [7] COREY L, WALD A. Maternal and neonatal herpes simplex virus infections[J]. N Engl J Med, 2009,361(14):1376-1385. [8] PINNINTI S G, KIMBERLIN D W. Neonatal herpes simplex virus infections[J]. Semin Perinatol,2018,42(3):168-175. [9] CAVINESS A C, DEMMLER G J, SWINT J M, et al. Cost-effectiveness analysis of herpes simplex virus testing and treatment strategies in febrile neonates[J]. Arch Pediatr Adolesc Med, 2008,162(7):665-674. [10] BRUNO E, PILLUS D, CHENG D, et al. During the emergency department evaluation of a well-appearing neonate with fever, should empiric acyclovir be initiated? [J] ] J Emerg Med,2018,54(2):261-265. [11] CAVINESS A C, DEMMLER G J, ALMENDAREZ Y, et al. The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates[J]. J Pediatr, 2008, 153(2):164-169. [12] PINNINTI S G, KIMBERLIN D W. Preventing herpes simplex virus in the newborn[J]. Clin Perinatol,2014,41(4):945-955. [13] KIMBERLIN D W. Herpes simplex virus infections of the newborn[J]. Semin Perinatol,2007,31(1):19-25. [14] WORKOWSKI K A, BOLAN G A. Sexually transmitted diseases treatment guidelines,2015[J]. Recomm Rep,2015,64(3):1-137. [15] KIMBERLIN D W, WHITLEY R J, WAN W, et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes[J]. N Engl J Med, 2011, 365(14):1284-1292. [16] GRONDIN A, BAUDOU E, PASQUET M, et al. Neonatal herpes simplex virus-1 recurrence with central nervous system disease in twins after completion of a six-month course of suppressive therapy: case report[J]. Neuropediatrics,2020,51(3):221-224. [17] MCPHERSON C C. Neonatal herpes simplex virus: the long road to improved outcomes[J]. Neonatal Netw,2020,39(2):92-98. [18] BHATTA A K, KEYAL U, LIU Y, et al. Vertical transmission of herpes simplex virus: an update[J]. J Dtsch Dermatol Ges,2018,16(6):685-692. [19] GOTTLIEB S L, JOHNSTON C. Future prospects for new vaccines against sexually transmitted infections[J]. Curr Opin Infect Dis,2017,30(1):77-86. |